As of the latest Form 4 filed Feb 13, 2026.
What Balchem Corporation insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Newest filing first — the 48 most recent filings for BCPC.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-02-13 | 2026-02-12 | van Gunsteren Job Leonard SVP and GM, Specialty Products | FTax | −58.00 | $177.49 | $10.3K | No | Form 4 ↗ |
| 2026-02-13 | 2026-02-12 | Reid Martin Luther SVP Chief Supply Chain Officer | FTax | −116.00 | $177.49 | $20.6K | No | Form 4 ↗ |
| 2026-02-13 | 2026-02-12 | Harris Theodore L Chairman, President & CEO | FTax | −844.00 | $177.49 | $150K | No | Form 4 ↗ |
| 2026-02-13 | 2026-02-12 | Backus William A. VP & Chief Accounting Officer | FTax | −70.00 | $177.49 | $12.4K | No | Form 4 ↗ |
| 2026-02-13 | 2026-02-12 | Boned Frederic SVP/GM, Human Nutri. & Health | FTax | −203.00 | $177.49 | $36.0K | No | Form 4 ↗ |
| 2026-02-13 | 2026-02-12 | Tignor Michael Brent SVP & Chief HR Officer | FTax | −165.00 | $177.49 | $29.3K | No | Form 4 ↗ |
| 2026-02-13 | 2026-02-12 | Miyata Hatsuki EVP, CLO, & Secretary | FTax | −181.00 | $177.49 | $32.1K | No | Form 4 ↗ |
| 2026-02-13 | 2026-02-12 | Bengtsson Carl Martin EVP & Chief Financial Officer | FTax | −302.00 | $177.49 | $53.6K | No | Form 4 ↗ |
| 2026-02-13 | 2026-02-11 | van Gunsteren Job Leonard SVP and GM, Specialty Products | FTax | −756.00 | $178.68 | $135K | No | Form 4 ↗ |
| 2026-02-13 | 2026-02-11 | van Gunsteren Job Leonard, SVP and GM, Specialty Products | AAward | +1.34K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-13 | 2026-02-11 | van Gunsteren Job Leonard, SVP and GM, Specialty Products | AAward | +430.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-13 | 2026-02-11 | Reid Martin Luther SVP Chief Supply Chain Officer | FTax | −1.08K | $178.68 | $194K | No | Form 4 ↗ |
| 2026-02-13 | 2026-02-11 | Reid Martin Luther, SVP Chief Supply Chain Officer | AAward | +2.36K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-13 | 2026-02-11 | Reid Martin Luther, SVP Chief Supply Chain Officer | AAward | +940.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-13 | 2026-02-11 | Harris Theodore L Chairman, President & CEO | FTax | −9.36K | $178.68 | $1.67M | No | Form 4 ↗ |
| 2026-02-13 | 2026-02-11 | Harris Theodore L, Chairman, President & CEO | AAward | +18.3K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-13 | 2026-02-11 | Harris Theodore L, Chairman, President & CEO | AAward | +7.35K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-13 | 2026-02-11 | Graham George SVP and Chief R&D Officer | AAward | +700.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-13 | 2026-02-11 | Backus William A. VP & Chief Accounting Officer | FTax | −865.00 | $178.68 | $155K | No | Form 4 ↗ |
| 2026-02-13 | 2026-02-11 | Backus William A., VP & Chief Accounting Officer | AAward | +1.66K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-13 | 2026-02-11 | Backus William A., VP & Chief Accounting Officer | AAward | +490.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-13 | 2026-02-11 | Boned Frederic SVP/GM, Human Nutri. & Health | FTax | −1.15K | $178.68 | $206K | No | Form 4 ↗ |
| 2026-02-13 | 2026-02-11 | Boned Frederic, SVP/GM, Human Nutri. & Health | AAward | +2.25K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-13 | 2026-02-11 | Boned Frederic, SVP/GM, Human Nutri. & Health | AAward | +2.87K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-13 | 2026-02-11 | Tignor Michael Brent SVP & Chief HR Officer | FTax | −991.00 | $178.68 | $177K | No | Form 4 ↗ |
| 2026-02-13 | 2026-02-11 | Tignor Michael Brent, SVP & Chief HR Officer | AAward | +1.93K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-13 | 2026-02-11 | Tignor Michael Brent, SVP & Chief HR Officer | AAward | +1.20K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-13 | 2026-02-11 | Miyata Hatsuki EVP, CLO, & Secretary | FTax | −877.00 | $178.68 | $157K | No | Form 4 ↗ |
| 2026-02-13 | 2026-02-11 | Miyata Hatsuki, EVP, CLO, & Secretary | AAward | +2.25K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-13 | 2026-02-11 | Miyata Hatsuki, EVP, CLO, & Secretary | AAward | +1.71K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-13 | 2026-02-11 | Bengtsson Carl Martin EVP & Chief Financial Officer | FTax | −2.42K | $178.68 | $432K | No | Form 4 ↗ |
| 2026-02-13 | 2026-02-11 | Bengtsson Carl Martin, EVP & Chief Financial Officer | AAward | +4.72K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-13 | 2026-02-11 | Bengtsson Carl Martin, EVP & Chief Financial Officer | AAward | +3.61K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-13 | 2026-02-11 | Wineinger Matthew David Director | AAward | +870.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-13 | 2026-02-11 | VICENTE MONICA Director | AAward | +870.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-13 | 2026-02-11 | Rigaud Olivier Director | AAward | +870.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-13 | 2026-02-11 | Knutson Daniel E Director | AAward | +870.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-13 | 2026-02-11 | Fish Kathleen B Director | AAward | +870.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-13 | 2026-02-11 | Fischer David B Director | AAward | +870.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-10 | 2026-02-08 | Backus William A. VP & Chief Accounting Officer | FTax | −322.00 | $173.16 | $55.8K | No | Form 4 ↗ |
| 2026-02-10 | 2026-02-08 | Miyata Hatsuki EVP, CLO, & Secretary | FTax | −343.00 | $173.16 | $59.4K | No | Form 4 ↗ |
| 2026-02-10 | 2026-02-08 | Harris Theodore L Chairman, President & CEO | FTax | −3.23K | $173.16 | $558K | No | Form 4 ↗ |
| 2026-02-10 | 2026-02-08 | Boned Frederic SVP/GM, Human Nutri. & Health | FTax | −430.00 | $173.16 | $74.5K | No | Form 4 ↗ |
| 2026-02-10 | 2026-02-08 | Reid Martin Luther SVP Chief Supply Chain Officer | FTax | −416.00 | $173.16 | $72.0K | No | Form 4 ↗ |
| 2026-02-10 | 2026-02-08 | van Gunsteren Job Leonard SVP and GM, Specialty Products | FTax | −258.00 | $173.16 | $44.7K | No | Form 4 ↗ |
| 2026-02-10 | 2026-02-08 | Bengtsson Carl Martin EVP & Chief Financial Officer | FTax | −863.00 | $173.16 | $149K | No | Form 4 ↗ |
| 2026-02-10 | 2026-02-08 | Tignor Michael Brent SVP & Chief HR Officer | FTax | −373.00 | $173.16 | $64.6K | No | Form 4 ↗ |
| 2026-02-10 | 2025-04-01 | Backus William A. VP & Chief Accounting Officer | FTax | −383.00 | $167.24 | $64.1K | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also BCPC’s full analysis or the market-wide insider trading feed. The tabs above jump to BCPC’s other SEC data.
Source: SEC Form 4 filings for BCPC, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.